ProMIS Neurosciences Inc. financial data

Symbol
PMN on Nasdaq
Location
Toronto, Ontario, Canada
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 224% % -7.3%
Debt-to-equity 83% % -79%
Return On Equity -337% % -1220%
Return On Assets -184% % -3426%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 53,811,110 shares 65%
Common Stock, Shares, Outstanding 53,811,110 shares 65%
Entity Public Float $29,700,000 USD
Weighted Average Number of Shares Outstanding, Basic 48,833,799 shares 63%
Weighted Average Number of Shares Outstanding, Diluted 48,833,799 shares 62%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $28,336,055 USD 232%
General and Administrative Expense $7,061,577 USD 15%
Operating Income (Loss) $35,397,632 USD -141%
Nonoperating Income (Expense) $6,114,367 USD -57%
Net Income (Loss) Attributable to Parent $29,283,265 USD -5098%
Earnings Per Share, Basic 0 USD/shares -1450%
Earnings Per Share, Diluted 0 USD/shares -1450%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $15,399,165 USD -28%
Assets, Current $21,458,147 USD -12%
Assets $21,458,147 USD -12%
Accounts Payable, Current $4,211,485 USD 167%
Accrued Liabilities, Current $7,999,562 USD 655%
Liabilities, Current $12,211,047 USD 363%
Liabilities $12,270,792 USD -29%
Accumulated Other Comprehensive Income (Loss), Net of Tax $371,184 USD 0%
Retained Earnings (Accumulated Deficit) $119,732,132 USD -32%
Stockholders' Equity Attributable to Parent $9,187,355 USD 26%
Liabilities and Equity $21,458,147 USD -12%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $4,926,866 USD 52%
Net Cash Provided by (Used in) Financing Activities $190,274 USD
Common Stock, Shares, Issued 53,811,110 shares 65%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $4,926,866 USD 51%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $15,399,165 USD -28%
Deferred Tax Assets, Valuation Allowance $31,883,000 USD 15%
Deferred Tax Assets, Gross $31,883,000 USD 15%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $2,778,873 USD 93%
Deferred Tax Assets, Operating Loss Carryforwards $24,850,000 USD 17%
Preferred Stock, Shares Issued 0 shares -100%
Unrecognized Tax Benefits $0 USD
Additional Paid in Capital $129,290,671 USD 32%
Preferred Stock, Shares Outstanding 0 shares -100%
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Share-based Payment Arrangement, Expense $1,277,646 USD 1644%
Interest Expense $76,775 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares